Detalhe da pesquisa
1.
Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
; 22(7): 1475-1486.e4, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38369224
2.
Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel Disease.
Am J Gastroenterol
; 118(1): 129-137, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36114773
3.
Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel Diseases.
Am J Gastroenterol
; 117(3): 462-469, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35029167
4.
Epidemic Spreading in Metapopulation Networks Coupled With Awareness Propagation.
IEEE Trans Cybern
; 53(12): 7686-7698, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054390
5.
Early life exposures as risk factors for non-esophageal eosinophilic gastrointestinal diseases.
Clin Res Hepatol Gastroenterol
; 47(7): 102170, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37352927
6.
Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID.
Inflamm Bowel Dis
; 28(10): 1497-1505, 2022 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34871388
7.
Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis
; 29(3): 483-486, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35830416